Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01636479 |
| Title | Phase 1 Safety Testing of SAR405838 |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Sanofi |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | NLD | FRA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Investigational Site Number 840101 | Boston | Massachusetts | 02114 | United States | Details | |
| Investigational Site Number 840001 | Boston | Massachusetts | 02115 | United States | Details | |
| Investigational Site Number 840002 | New York | New York | 10021 | United States | Details | |
| Investigational Site Number 250001 | Villejuif | 94805 | France | Details | ||
| Investigational Site Number 528001 | Amsterdam | 1066 CX | Netherlands | Details | ||
| Investigational Site Number 528003 | Rotterdam | 3075 EA | Netherlands | Details | ||
| Investigational Site Number 528002 | Utrecht | 3584 CX | Netherlands | Details |